Article
An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL).
Journal of Clinical Oncology
(2013)
Disciplines
Publication Date
May 20, 2013
Citation Information
Jeffrey Alan Sosman, Salvador Martin-Algarra, Jedd D. Wolchok, William Howard Sharfman, et al.. "An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL)." Journal of Clinical Oncology Vol. 31 (2013) Available at: http://works.bepress.com/walter-urba/141/